Summary
Elevance Health, Inc. (ELV) has filed an 8-K report on July 15, 2026, primarily to disclose its financial results for the second quarter ended June 30, 2026, via a furnished press release (Exhibit 99.1). While the filing itself does not contain detailed operational commentary, investors should refer to the referenced press release for specifics on revenue, earnings, and other key financial metrics. The company is reminding investors that information furnished under Item 2.02 is not considered "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, nor will it be automatically incorporated by reference into future SEC filings unless explicitly stated.
Key Highlights
- 1Elevance Health announced its Q2 2026 financial results via a press release furnished with the 8-K filing.
- 2The filing primarily serves to make the Q2 2026 earnings press release publicly available.
- 3Investors must consult Exhibit 99.1 (the press release) for detailed financial performance data for the quarter ended June 30, 2026.
- 4The report includes the standard disclaimer that information furnished under Item 2.02 is not deemed "filed" under Section 18 of the Exchange Act.
- 5Information provided in this 8-K and its exhibits will not be automatically incorporated into future SEC filings without specific reference.
Frequently Asked Questions
The specific financial results for the quarter ended June 30, 2026, are detailed in the press release furnished as Exhibit 99.1 to this 8-K filing.
This 8-K filing itself does not contain the detailed financial metrics. Investors need to access and review the press release (Exhibit 99.1) to find information on revenue, earnings per share, and other key performance indicators for the second quarter of 2026.
No, Elevance Health explicitly states that the information furnished under Item 2.02 of this report, including the press release, is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934. Therefore, it does not carry the same legal implications as information that is formally filed.
The filing includes a disclaimer stating that unless expressly set forth by specific reference in such filings, none of the information furnished in this report shall be incorporated by reference in any future filing under the Securities Act of 1933 or the Securities Exchange Act of 1934.